AmbioPharm Inc., a provider of peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 square meters of manufacturing, quality control and administrative space.   “We have added 4 new buildings which add to our solid-phase and liquid-phase peptide facilities at our Shanghai production site positioning AmbioPharm as the go-to source for all peptide API needs that our partners have. This is in addition to the manufacturing expansion which was compl...